News

A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...
In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...
In the long and often dispiriting quest to cure cancer, the 1998 approval of the drug Herceptin was a tremendously hopeful moment. This drug for breast cancer was the first to use a tumor-specific ...
Yet, even as we celebrate these strengths, it is clear that the next phase of growth will not be driven by volume alone. To remain globally competitive and meet the complex health needs of the future, ...
Govt caps prices of 71 drugs, including those of diabetes and cancer: How will this impact your medical bill?
The National Pharmaceutical Pricing Authority (NPPA) has revised the prices of 71 essential drug formulations, encompassing ...
The central government has regulated prices for 71 essential medicines. This includes drugs for breast cancer, allergies, and ...
Only with the adoption of digital imaging and AI-powered analysis will next-generation precision oncology therapies reach ...
Treatment using Imcranib 100 is now available at Chulabhorn Hospital, signicantly reducing treatment costs and increasing ...
Thailand has produced its first locally developed targeted therapy pill for cancer treatment. Imcranib 100 is the result of the scientific vision and leadership of Her Royal Highness Princess ...
Cancer Antibody Drug Conjugates Treatment Market USD 50 Billion Opportunity Says Kuick Research. Delhi, July 11, 2025 (GLOBE ...
Tanvex Biopharma Inc. said its U.S. subsidiary, Tanvex Biopharma U.S.A. Inc., received an FDA complete response letter (CRL) on Jan. 3 for its TX-05 BLA, a biosimilar that references Roche AG’s ...